| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-08 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.16 | 7e-07 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-06 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.15 | 8e-06 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.21 | 8e-06 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.14 | 8e-06 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |